KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Cash from Operations (2016 - 2025)

Sarepta Therapeutics has reported Cash from Operations over the past 15 years, most recently at 131206000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 42.54% year-over-year to 131206000.0; the TTM value through Dec 2025 reached 205479000.0, changed 0.15%, while the annual FY2025 figure was 205479000.0, 0.15% changed from the prior year.
  • Cash from Operations for Q4 2025 was 131206000.0 at Sarepta Therapeutics, up from 14585000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 261337000.0 in Q2 2025 and troughed at 583437000.0 in Q1 2025.
  • A 5-year average of 84038850.0 and a median of 81545500.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: plummeted 215.05% in 2022 and later soared 1649.01% in 2025.
  • Year by year, Cash from Operations stood at 29326000.0 in 2021, then plummeted by 215.05% to 92392000.0 in 2022, then skyrocketed by 40.84% to 54657000.0 in 2023, then soared by 268.41% to 92046000.0 in 2024, then surged by 42.54% to 131206000.0 in 2025.
  • Business Quant data shows Cash from Operations for SRPT at 131206000.0 in Q4 2025, 14585000.0 in Q3 2025, and 261337000.0 in Q2 2025.